Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c

Lineage Cell Therapeutics (NYSE: LCTX) reported Q4 EPS of $0.02. Revenue for the quarter came in at $2.9 million.

For earnings history and earnings-related data on Lineage Cell Therapeutics (LCTX) click here.

You May Also Be Interested In

• SpaceX: Next Starship Flight Will Be Revenue Generating - Bloomberg
• ViaSat (VSAT) 3400 contracts of Dember 110 calls trade, share price up 2.3%
• River Valley Community Bancorp founding director Michael Wheeler dies at 76